Episode Details
Back to EpisodesClozapine Monitoring: New Guidelines for the Post-REMS Era
Published 5 months, 3 weeks ago
Description
In this episode, we explore new international guidelines for clozapine monitoring following the FDA's REMS rescission. Should patients on stable clozapine continue lifelong monthly blood draws, or can we safely reduce monitoring after two years? Dr. Seeber discusses how these evidence-based recommendations balance patient burden with safety.
Faculty: Oliver Freudenreich, M.D.
Host: Richard Seeber, M.D.